Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)
China · Delayed Price · Currency is CNY 31.50
+0.23 (0.74%)
Apr 29, 2026, 11:54 AM CST
SHE:003017 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 101.59 | 100.06 | 63.75 | 50.01 | 80.73 | 70.01 |
Depreciation & Amortization | 72.55 | 72.55 | 68.32 | 69.67 | 60.25 | 45.1 |
Other Amortization | 0.28 | 0.28 | 0.6 | 0.05 | 0.05 | 0.05 |
Loss (Gain) From Sale of Assets | -2.05 | -2.05 | -0.09 | 0.17 | -3.41 | -0.12 |
Asset Writedown & Restructuring Costs | 22.52 | 22.52 | 7.98 | 17.02 | 0.19 | 1.89 |
Loss (Gain) From Sale of Investments | -2.79 | -2.79 | -2.2 | -3.21 | -4.62 | -11.28 |
Provision & Write-off of Bad Debts | - | - | 1.08 | -1.58 | 1.77 | 0.18 |
Other Operating Activities | -42.03 | 5.3 | 9.6 | 9.17 | 6.49 | 3.95 |
Change in Accounts Receivable | -128.73 | -128.73 | -94.51 | 5.99 | -65.96 | -40.69 |
Change in Inventory | 9.88 | 9.88 | 30.2 | -28.27 | 34.56 | -93.26 |
Change in Accounts Payable | 68.79 | 68.79 | -30.75 | 59.87 | -6.8 | -16.73 |
Change in Other Net Operating Assets | 13.05 | 13.05 | 4.46 | 7.27 | 11.95 | - |
Operating Cash Flow | 114.3 | 160.11 | 66.19 | 182.42 | 91.89 | -35.16 |
Operating Cash Flow Growth | 5.22% | 141.87% | -63.71% | 98.53% | - | - |
Capital Expenditures | -102.95 | -76.38 | -63.45 | -103.63 | -104.65 | -93.43 |
Sale of Property, Plant & Equipment | 4 | 3.93 | 0.94 | 1.36 | 6.85 | 0.72 |
Investment in Securities | 30.64 | 40.64 | -106 | 241.9 | -20.48 | 89.35 |
Other Investing Activities | 2.42 | 2.91 | 1.2 | 5.45 | 8.4 | 12.25 |
Investing Cash Flow | -65.88 | -28.9 | -167.3 | 145.08 | -109.88 | 8.89 |
Long-Term Debt Issued | - | 613.07 | 715.86 | 519.38 | 556.51 | 138.66 |
Total Debt Issued | 758.07 | 613.07 | 715.86 | 519.38 | 556.51 | 138.66 |
Long-Term Debt Repaid | - | -615.22 | -599.44 | -552.45 | -454.84 | -10.96 |
Total Debt Repaid | -664.2 | -615.22 | -599.44 | -552.45 | -454.84 | -10.96 |
Net Debt Issued (Repaid) | 93.87 | -2.16 | 116.42 | -33.07 | 101.67 | 127.7 |
Issuance of Common Stock | - | - | 35.85 | - | 42.36 | - |
Repurchase of Common Stock | - | - | -41.96 | - | -88.1 | - |
Common Dividends Paid | -54.45 | -54.66 | -42.71 | -42.61 | -39.06 | -38.31 |
Dividends Paid | -54.45 | -54.66 | -42.71 | -42.61 | -39.06 | -38.31 |
Other Financing Activities | 16.04 | 14 | -1.04 | - | - | - |
Financing Cash Flow | 55.46 | -42.81 | 66.56 | -75.68 | 16.87 | 89.4 |
Foreign Exchange Rate Adjustments | -1.63 | -0.23 | 0.27 | -0.1 | -0.96 | -0 |
Net Cash Flow | 102.25 | 88.16 | -34.28 | 251.73 | -2.09 | 63.13 |
Free Cash Flow | 11.35 | 83.72 | 2.74 | 78.8 | -12.76 | -128.59 |
Free Cash Flow Growth | -79.86% | 2950.92% | -96.52% | - | - | - |
Free Cash Flow Margin | 1.06% | 8.01% | 0.30% | 8.57% | -1.21% | -16.42% |
Free Cash Flow Per Share | 0.14 | 1.02 | 0.03 | 0.98 | -0.16 | -1.53 |
Cash Income Tax Paid | 32.89 | 31.89 | 24.47 | 31.05 | 0.12 | 11.65 |
Levered Free Cash Flow | 91.13 | 145.47 | -14.49 | 71.45 | 44.17 | -103.2 |
Unlevered Free Cash Flow | 91.13 | 145.47 | -10.26 | 75.29 | 47.59 | -101.47 |
Change in Working Capital | -35.77 | -35.77 | -82.85 | 41.12 | -49.56 | -144.93 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.